Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phenotypic Study of Safety, Tolerability, Reactogenicity, Immunogenicity, and Virus Shedding With Post-Vaccination Infections of Emergency-Use-Authorized Vaccines Against COVID-19

NCT04832932 is registered in ClinicalTrials.gov with Mebo Research, Inc. as lead sponsor.

NCT NCT04832932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phenotypic Study of Safety, Tolerability, Reactogenicity, Immunogenicity, and Virus Shedding With Post-Vaccination Infections of Emergency-Use-Authorized Vaccines Against COVID-19
Lead sponsor
Mebo Research, Inc.
Phase
Observational
Overall status
Unknown status
Start date
January 5, 2021
Completion date
January 5, 2025
Enrollment
2,000 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines